Jan 12, 2021 / 02:00PM GMT
Operator
Welcome to the Medivir Press conference 2021. (Operator Instructions) We'll try to keep this call to 30 minutes.
Today, I'm pleased to present CEO, Yilmaz Mahshid. Please go ahead of your meeting.
Yilmaz Mahshid - Medivir AB(publ)-CEO&President
Thank you, operator, and thank you, everyone, who has called into this call.
Today, we will cover the announcement we did last night, where we entered into exclusive licensing agreement with IGM Biosciences for birinapant.
Next slide, please. So our cautionary statement, it is available on paid. So please take a look at that. Next slide, please. So today's presenter here is me, myself, Yilmaz Mahshid, President and CEO of Medivir, we do also have with us Fred Schwarzer, President and CEO of IGM Biosciences.
We do also have with us our Chief Scientific Officer; Fredrik Ãberg, Medivir, who will be covering the mechanism action of birinapant . Next slide, please. So this is just an executive summer of Medivir. And maybe some new
Medivir AB to Discuss Exclusive Licensing Agreement with IGM Biosciences for Birinapant Call Transcript
Jan 12, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers